| |
Acomplia launched in many European countries
By Steve Jackson
Acomplia, the much anticipated miracle obesity drug (Rimonabant) went on sale in Sweden this month, but the far-more exciting news for manufacturer Sanofi-Aventis was that the cost of the weight-loss pill will be reimbursable by Sweden's public health service.
The health services in Denmark and Ireland have also agreed to reimburse patients for the drug, but in Germany - the European Union's largest market - the regulatory body that decides which medicines will be covered by insurers classified Acomplia as a "lifestyle" drug not eligible for reimbursement.
With the addition of Sweden, Acomplia is now on sale in eight European Union countries as well as in Argentina. It has been approved for sale in Mexico, but will not be available there until the start of 2007. Sanofi-Aventis said it expects to begin selling Acomplia in Mexico by January 2007.
Acomplia diet pill is still stalled at the U.S. Food and Drug Administration. UD FDA has asked Sanofi for some more additional information before it can get permission for sale. Sanofi has responded with full details in the month of October and analysts hope to hear from FDA either in two months or it might take another six months for the decision to come by. Acomplia has not been approved in Canada.
The Mexican Ministry of Health approved the Acomplia diet pill not only as an adjunct to diet and exercise for obese patients or overweight people at risk of diabetes and heart disease, but also said Acomplia can be used with standard treatments metformin or sulfonylurea to improve blood sugar levels in diabetics.
There have been speculations that Rimonabant, while on sale in Europe as Acomplia, would be marketed under some other name in the United States - probably Zimulti or Acomplia aft.
Acomplia, the weight loss diet pill, from Sanofi, blocks a cellular receptor found in the brain and fat cells involved with experiencing pleasurable sensations. By blocking this receptor, Acomplia dampens appetite. It's now the first drug to prove that it can help obese people take weight off and keep it off for more than one year according to the new research. Beyond this consideration, it also fights nicotine addiction, and can improve cholesterol levels and various other heart disease risk factors.
With obesity affecting 100 million people in the United States and Europe, analysts say such a drug could generate up to $6 billion a year in sales by the end of the decade. That would put Acomplia on the top shelf of the medicine cabinet, with the likes of Pfizer's Lipitor and Merck's Zocor cholesterol treatments.
The magic bullet is still being tested and not yet proved itself but it is already a rage and has favorable reports. Acomplia information is available on online pharmacies offering to buy Acomplia (Rimonabant) online. There are many Acomplia pharmacies in UK where one can order Acomplia diet pills online. To buy cheap Acomplia (Rimonabant) online could be dangerous as they could be imitations of the original. So be sure you buy the right drug.
About the Author
Steve Jackson is an associated editor and a contributing author to the Eu-internet-pharmacy.com for distinct article sites/journals. Please feel free to visit http://www.eu-internet-pharmacy.com for more information on Cialis, Acomplia.
Article Source: http://www.simplysearch4it.com/article/43179.html
| If you wish to add the above article to your website or newsletters then please include the "Article Source: http://www.simplysearch4it.com/article/43179.html" as shown above and make it hyperlinked. |
| Some other articles by Steve Jackson | Eat to Satisfy not to Stuff
Overeating and obesity are directly proportional to each other in general and unfortunately most people continue to eat anything and in any quantity even after being aware of consequences of overeating. There is no doubt ...
|
|
| |
|
|
|
